A Phase 1, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics of Iberdomide in Subjects with Mild, Moderate, or Severe Hepatic Impairment Compared with Healthy Subjects

• Main Authors: Cheng Y (Author), Ye Y (Author), Gaudy A (Author), Ghosh A (Author), Xue Y (Author), Wang A (Author), Zhou S (Author), Li Y (Author)
• Format: Book
• Published: Dove Medical Press, 2023-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Yiming Cheng,1 Ying Ye,1 Allison Gaudy,1 Atalanta Ghosh,2 Yongjun Xue,3 Alice Wang,1 Simon Zhou,1 Yan Li1 1Clinical Pharmacology & Pharmacometrics, Bristol Myers Squibb, Princeton, NJ, USA; 2Global Biometrics and Data Sciences, Bristol Myers Squibb, Princeton, NJ, USA; 3Nonclinical Research &...